Published by Michele Maatouk on 15th December 2020
(Sharecast News) - Eli Lilly said on Tuesday that it has agreed to buy gene therapy company Prevail Therapeutics in a deal valued at $1.04bn, as it boosted its guidance for 2020.
URL: http://www.digitallook.com/dl/news/story/31516847/...